vs
Academy Sports & Outdoors, Inc.(ASO)とRevvity(RVTY)の財務データ比較。上の社名をクリックして会社を切り替えられます
Academy Sports & Outdoors, Inc.の直近四半期売上が大きい($1.4B vs $772.1M、Revvityの約1.8倍)。Revvityの純利益率が高く(12.7% vs 5.2%、差は7.6%)。Revvityの前年同期比売上増加率が高い(5.9% vs 3.0%)。Revvityの直近四半期フリーキャッシュフローが多い($161.8M vs $-13.6M)。過去8四半期でRevvityの売上複合成長率が高い(9.0% vs -12.2%)
Academy Sports & Outdoorsはアメリカの大手スポーツ・アウトドア用品小売チェーンで、本社はテキサス州ハリス郡に所在します。74年間にわたりゴックマン家が所有する非公開企業でしたが、2011年にKKRに買収され、2020年10月にナスダックに上場しました。
レブィティ(Revvity, Inc.)は米国のライフサイエンス・診断事業を手がける企業で、製薬およびバイオテクノロジー業界を主な顧客とし、特に新たな細胞治療や遺伝子治療の開発に関連するサービス・製品を提供している。前身は多岐にわたる事業を展開してきた老舗企業パーキンエルマーである。
ASO vs RVTY — 直接比較
損益計算書 — Q3 FY2026 vs Q4 FY2025
| 指標 | ||
|---|---|---|
| 売上 | $1.4B | $772.1M |
| 純利益 | $71.6M | $98.4M |
| 粗利率 | 35.7% | — |
| 営業利益率 | 7.3% | 14.5% |
| 純利益率 | 5.2% | 12.7% |
| 売上前年比 | 3.0% | 5.9% |
| 純利益前年比 | 8.8% | 3.9% |
| EPS(希薄化後) | $1.05 | $0.86 |
緑 = その指標でリード。会計年度がずれている場合は期間が異なる場合あり
8四半期 売上・利益トレンド
並べて比較する四半期履歴。決算期がずれていても暦四半期で整列
| Q4 25 | $1.4B | $772.1M | ||
| Q3 25 | $1.6B | $698.9M | ||
| Q2 25 | $1.4B | $720.3M | ||
| Q1 25 | $1.7B | $664.8M | ||
| Q4 24 | $1.3B | $729.4M | ||
| Q3 24 | $1.5B | $684.0M | ||
| Q2 24 | $1.4B | $691.7M | ||
| Q1 24 | $1.8B | $649.9M |
| Q4 25 | $71.6M | $98.4M | ||
| Q3 25 | $125.4M | $46.7M | ||
| Q2 25 | $46.1M | $53.9M | ||
| Q1 25 | $133.6M | $42.2M | ||
| Q4 24 | $65.8M | $94.6M | ||
| Q3 24 | $142.6M | $94.4M | ||
| Q2 24 | $76.5M | $55.4M | ||
| Q1 24 | $168.2M | $26.0M |
| Q4 25 | 35.7% | — | ||
| Q3 25 | 36.0% | 53.6% | ||
| Q2 25 | 34.0% | 54.5% | ||
| Q1 25 | 32.2% | 56.5% | ||
| Q4 24 | 34.0% | — | ||
| Q3 24 | 36.1% | 56.3% | ||
| Q2 24 | 33.4% | 55.7% | ||
| Q1 24 | 33.3% | 54.6% |
| Q4 25 | 7.3% | 14.5% | ||
| Q3 25 | 10.8% | 11.7% | ||
| Q2 25 | 5.1% | 12.6% | ||
| Q1 25 | 9.2% | 10.9% | ||
| Q4 24 | 6.8% | 16.3% | ||
| Q3 24 | 12.3% | 14.3% | ||
| Q2 24 | 7.5% | 12.4% | ||
| Q1 24 | 11.4% | 6.8% |
| Q4 25 | 5.2% | 12.7% | ||
| Q3 25 | 7.8% | 6.7% | ||
| Q2 25 | 3.4% | 7.5% | ||
| Q1 25 | 8.0% | 6.4% | ||
| Q4 24 | 4.9% | 13.0% | ||
| Q3 24 | 9.2% | 13.8% | ||
| Q2 24 | 5.6% | 8.0% | ||
| Q1 24 | 9.4% | 4.0% |
| Q4 25 | $1.05 | $0.86 | ||
| Q3 25 | $1.85 | $0.40 | ||
| Q2 25 | $0.68 | $0.46 | ||
| Q1 25 | $1.85 | $0.35 | ||
| Q4 24 | $0.92 | $0.77 | ||
| Q3 24 | $1.95 | $0.77 | ||
| Q2 24 | $1.01 | $0.45 | ||
| Q1 24 | $2.19 | $0.21 |
貸借対照表と財務力
直近四半期の流動性・レバレッジ・純資産のスナップショット
| 指標 | ||
|---|---|---|
| 現金・短期投資手元流動性 | $289.5M | $919.9M |
| 総負債低いほど良い | — | — |
| 株主資本純資産 | $2.1B | $7.3B |
| 総資産 | $5.4B | $12.2B |
| 負債/資本比率低いほどレバレッジが低い | — | — |
8四半期トレンド — 暦四半期で整列
| Q4 25 | $289.5M | $919.9M | ||
| Q3 25 | $300.9M | $931.4M | ||
| Q2 25 | $285.1M | $991.8M | ||
| Q1 25 | $288.9M | $1.1B | ||
| Q4 24 | $296.0M | $1.2B | ||
| Q3 24 | $324.6M | $1.2B | ||
| Q2 24 | $378.1M | $2.0B | ||
| Q1 24 | $347.9M | $1.7B |
| Q4 25 | $2.1B | $7.3B | ||
| Q3 25 | $2.1B | $7.4B | ||
| Q2 25 | $1.9B | $7.6B | ||
| Q1 25 | $2.0B | $7.6B | ||
| Q4 24 | $2.0B | $7.7B | ||
| Q3 24 | $2.0B | $7.9B | ||
| Q2 24 | $1.9B | $7.9B | ||
| Q1 24 | $2.0B | $7.8B |
| Q4 25 | $5.4B | $12.2B | ||
| Q3 25 | $5.3B | $12.1B | ||
| Q2 25 | $5.2B | $12.4B | ||
| Q1 25 | $4.9B | $12.4B | ||
| Q4 24 | $5.1B | $12.4B | ||
| Q3 24 | $4.9B | $12.8B | ||
| Q2 24 | $4.9B | $13.4B | ||
| Q1 24 | $4.7B | $13.4B |
キャッシュフローと資本効率
再投資後に実際に生み出すキャッシュ。純利益より操作が難しい
| 指標 | ||
|---|---|---|
| 営業キャッシュフロー直近四半期 | $49.0M | $182.0M |
| フリーキャッシュフロー営業CF - 設備投資 | $-13.6M | $161.8M |
| FCFマージンFCF / 売上 | -1.0% | 21.0% |
| 設備投資強度設備投資 / 売上 | 4.5% | 2.6% |
| キャッシュ転換率営業CF / 純利益 | 0.68× | 1.85× |
| 直近12ヶ月FCF直近4四半期 | $191.4M | $509.4M |
8四半期トレンド — 暦四半期で整列
| Q4 25 | $49.0M | $182.0M | ||
| Q3 25 | $78.6M | $138.5M | ||
| Q2 25 | $157.5M | $134.3M | ||
| Q1 25 | $140.2M | $128.2M | ||
| Q4 24 | $96.9M | $174.2M | ||
| Q3 24 | $91.3M | $147.9M | ||
| Q2 24 | $199.7M | $158.6M | ||
| Q1 24 | $234.7M | $147.6M |
| Q4 25 | $-13.6M | $161.8M | ||
| Q3 25 | $21.8M | $120.0M | ||
| Q2 25 | $106.6M | $115.5M | ||
| Q1 25 | $76.4M | $112.2M | ||
| Q4 24 | $34.4M | $149.8M | ||
| Q3 24 | $50.1M | $125.6M | ||
| Q2 24 | $167.4M | $136.6M | ||
| Q1 24 | $178.9M | $129.7M |
| Q4 25 | -1.0% | 21.0% | ||
| Q3 25 | 1.4% | 17.2% | ||
| Q2 25 | 7.9% | 16.0% | ||
| Q1 25 | 4.6% | 16.9% | ||
| Q4 24 | 2.6% | 20.5% | ||
| Q3 24 | 3.2% | 18.4% | ||
| Q2 24 | 12.3% | 19.7% | ||
| Q1 24 | 10.0% | 20.0% |
| Q4 25 | 4.5% | 2.6% | ||
| Q3 25 | 3.5% | 2.6% | ||
| Q2 25 | 3.8% | 2.6% | ||
| Q1 25 | 3.8% | 2.4% | ||
| Q4 24 | 4.6% | 3.4% | ||
| Q3 24 | 2.7% | 3.3% | ||
| Q2 24 | 2.4% | 3.2% | ||
| Q1 24 | 3.1% | 2.7% |
| Q4 25 | 0.68× | 1.85× | ||
| Q3 25 | 0.63× | 2.97× | ||
| Q2 25 | 3.42× | 2.49× | ||
| Q1 25 | 1.05× | 3.03× | ||
| Q4 24 | 1.47× | 1.84× | ||
| Q3 24 | 0.64× | 1.57× | ||
| Q2 24 | 2.61× | 2.87× | ||
| Q1 24 | 1.40× | 5.67× |
財務フロー比較
売上 → 粗利 → 営業利益 → 純利益のサンキー図
セグメント別売上内訳
ASO
| Outdoors | $445.1M | 32% |
| Apparel | $349.8M | 25% |
| Footwear | $292.4M | 21% |
| Sports And Recreation | $288.7M | 21% |
| Other | $7.6M | 1% |
RVTY
| Immunodiagnostics | $240.8M | 31% |
| Life Sciences | $191.4M | 25% |
| Reproductive Health | $149.3M | 19% |
| Segment Operating Income | $132.0M | 17% |
| Software | $62.3M | 8% |